fluconazole has been researched along with Hepatitis B in 3 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, YH | 1 |
| Tan, F | 1 |
| Li, M | 1 |
| Liu, J | 1 |
| Wang, X | 1 |
| Yuan, Y | 1 |
| Zhong, XF | 1 |
| Peng, FH | 1 |
| Yeung, VA | 1 |
| Azzam, R | 1 |
| Dendle, C | 1 |
| Graham, M | 1 |
| Woolley, IJ | 1 |
| Korman, TM | 1 |
| Jariwala, S | 1 |
| Vernon, N | 1 |
| de Vos, G | 1 |
3 other studies available for fluconazole and Hepatitis B
| Article | Year |
|---|---|
Comparisons of presentations and outcomes of cryptococcal meningitis between patients with and without hepatitis B virus infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Child; Cryptococcus; Female; Flucona | 2014 |
Cryptococcemia in primary HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cry | 2016 |
A novel method of desensitization for fluconazole hypersensitivity in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 2011 |